Mehta Named Deputy Director at Miami Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MINESH MEHTA joined Miami Cancer Institute at Baptist Health South Florida as deputy director and chief of radiation oncology.

Mehta comes to Baptist Health from the University of Maryland School of Medicine, where he served as medical director of the Maryland Proton Treatment Center in Baltimore—the area’s first proton treatment center, which he helped to launch.

Mehta was also the university’s associate director of clinical research in the Department of Radiation Oncology. Prior to his time at Maryland, he held academic, research and administrative leadership positions at Northwestern University and the University of Wisconsin, where he was appointed chairman of the medical school’s Department of Human Oncology and led research studies, technology development and expansion at the University of Wisconsin Cancer Center. He also headed the university’s brain tumor program for more than 15 years. At the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, Mehta was co-director of the Radiation Oncology Residency Training Program.

The Miami Cancer Institute’s new $430-million proton therapy facility, opening in 2016 and located on the Baptist Hospital of Miami campus, expects to treat its first patient with proton therapy in 2017.

YOU MAY BE INTERESTED IN

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login